✦ LIBER ✦

Sa2051 A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of RM-131 in Patients With Chronic Constipation

✍ Scribed by Acosta, Andres; Kolar, Gururaj; Iturrino, Johanna; Szarka, Lawrence A.; Boldingh, Amy; Burton, Duane D.; Ryks, Michael; Rhoten, Deborah L.; Zinsmeister, Alan R.; Camilleri, Michael

Book ID: 123079464
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 220 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)61318-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

929a A Phase 2, Randomized, Double-blind

929a A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis

✍ Lembo, Anthony; Camilleri, Michael; McCallum, Richard W.; Sastre, Ramon F.; Bret 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A phase 2, double-blind, randomized, pla

A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation

✍ Webster, Lynn; Dhar, Sunita; Eldon, Michael; Masuoka, Lorianne; Lappalainen, Jaa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 320 KB

1052 Randomized Double-Blind Placebo-Con

1052 Randomized Double-Blind Placebo-Controlled Trial to Evaluate Efficacy and Safety of Prucalopride (Resolor®) in Elderly Patients with Chronic Constipation

✍ Stefan A. Mueller-Lissner; An Rykx; Rene Kerstens; Lieve Vandeplassche 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Lubiprostone, a locally acting chloride

Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety

✍ J. F. JOHANSON; R. UENO 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

46 A Phase 2a Randomized Placebo-Control

46 A Phase 2a Randomized Placebo-Controlled Double-Blind Multi-Center Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Patients With Moderately Active Ulcerative Colitis

✍ Severine Vermeire; Paul J. Rutgeerts; Geert R. D'Haens; Martine De Vos; Brian Br 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and pharmacodynamics of AT1001 in patients with Fabry disease and AT1001-responsive GLA mutations

✍ Mathews Adera; Chemise Overton; Pol Boudes 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB